ASCAT 2023 | The Lancet Commission on sickle cell disease
David Rees
• 27 Oct 2023
David Rees, FRCP, FRCPath, FRCPCH, King’s College London, London, UK, speaks on the Lancet Commission on Sickle Cell Disease (SCD) which has been in development for four years and will be translated into action over the following decades. The commission aims to address all aspects of SCD, including epidemiology; screening; education and training; and both the currently available treatments, and those in development. This interview was recorded at the 18th Annual Scientific Conference on Sickle Cell and Thalassemia (ASCAT) 2023, held in London, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
